Association between the CCK-A receptor gene and panic disorder

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 118 B, Issue 1, 2003, Pages 29-31

  Ise, Kiminobu ^a   Akiyoshi, Jotaro ^a   Horinouchi, Yukiko ^a   Tsutsumi, Takashi ^a   Isogawa, Koichi ^a   Nagayama, Haruo ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Association study; Cholecystokinin; Panic disorder; Polymorphism

Indexed keywords

CHOLECYSTOKININ A RECEPTOR; GENE PRODUCT; CHOLECYSTOKININ RECEPTOR;

ADULT; ALLELE; ARTICLE; CCKAR GENE; CHI SQUARE DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTRON; MALE; PANIC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; GENETICS; GENOTYPE; JAPAN;

ANIMALIA;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; PANIC DISORDER; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ;

EID: 0042320343     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Binkley K, King N, Poonai N, Seeman P, Ulpian C, Kennedy J. 2001. Idiopathic environmental intolerance: Increased prevalence of panic disorder-associated cholecystokinin B receptor allele 7. J Allergy Clin Immunol 107:887-890.
2. Bowen T, Guy CA, Craddock N, Cardno AG, Williams NM, Spurlock G, Murphy KC, Jones LA, Gray M, Sanders RD, McCarthy G, Chandy KG, Fantino E, Kalman K, Gutman GA, Gargus JJ, Williams J, McGuffin P, Owen MJ, O'Donovan MC. 1998. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia. Mol Psychiatry 3:266-269.
3. Bradwejn J, Koszycki D, Meterissian G. 1990. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry 35:83-85.
4. Bradwejn J, Koszycki D, Couetoux du Tertre A, van Megen H, den Boer J, Westenberg H. 1994. The panicogenic effects of cholecystokinintetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486-493.
5. de Montigny C. 1989. Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. Arch Gen Psychiatry 46:511-517.
6. Griebel G, Perrault G, Sanger DJ. 1997. CCK receptor antagonists in animal models of anxiety: Comparison between exploration tests, conflict procedures, and a model based on defensive behaviours. Behav Pharmacol 8:549-560.
7. Hamilton SP, Slager SL, Helleby L, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. 2001. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiatry 6: 59-65.
8. Huston JP, Schildein S, Gerhardt P, Privou C, Fink H, Hasenohrl RU. 1998. Modulation of memory, reinforcement, and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s. Pept 19:27-37.
9. Kato T, Wang ZW, Zoega T, Crowe RR. 1996. Missense mutation of the cholecystokinin B receptor gene: Lack of association with panic disorder. Am J Med Genet 67:401-405.
10. Kennedy JL, Bradwejn J, Koszycki D, King N, Crowe R, Vincent J, Fourie O. 1999. Investigation of cholecystokinin system genes in panic disorder. Mol Psychiatry 4:284-285.
11. Kobayashi S, Ohta M, Miyasaka K, Funakoshi A. 1996. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci Lett 214:61-64.
12. Kramer MS, Cutler NR, Ballenger JC, Patterson WM, Mendels J, Chenault A, Shrivastava R, Matzura-Wolfe D, Lines C, Reines S. 1995. A placebo-controlled trial of L-365, 260, a CCKB antagonist, in panic disorder. Biol Psychiatry 37:462-466.
13. Monnikes H, Lauer G, Arnold R. 1997. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex, and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res 770:277-288.
14. Rupniak NM, Schaffer L, Siegl P, Iversen SD. 1993. Failure of intravenous pentagastrin challenge to induce panic-like effects in Rhesus monkeys. Neuropeptides 25:115-119.
15. Sham PC, Curtis D. 1995. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105.
16. Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. 1991. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA 88:1130-1133.
17. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Suzuki T. 2001. Linked polymorphisms (-333G > T and -286A > G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia. Psychiatry Res 103:147-155.
18. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H. 2000. Novel polymorphisms of the human cholecystokinin A receptor gene: An association analysis with schizophrenia. Am J Med Genet 96:141-145.
19. Tsutsumi T, Akiyoshi J, Isogawa K, Kohno Y, Hikichi T, Nagayama H. 1999. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158. Neuropeptides 33:483-486.
20. van Megen HJ, Westenberg HG, den Boer JA, Kahn RS. 1996. Cholecystokinin in anxiety. Eur Neuropsychopharmacol 6:263-280.
21. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T. 2001. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108:837-848.
22. Yamamoto Y, Akiyoshi J, Kiyota A, Katsuragi S, Tsutsumi T, Isogawa K, Nagayama H. 2000. Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor. Brain Res Bull 53:789-792.
23. Zhang XY, Zhou DF, Zhang PY, Wei J. 2000. The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Mol Psychiatry 5:239-240.